Award
NIH Reporter #5R01HL151444-04
Cell-specific role and therapeutic potential of KCa3.1 in atherosclerosis
Recipient
University of Missouri-Columbia, Columbia, MO, United States
Award Amount
$740,989.00
Ceiling
$740,989.00
Awarded
February 26, 2025
Identifier
5R01HL151444-04
Research project funded by the National Heart Lung and Blood Institute to study the role of KCa3.1 in atherosclerosis and test FDA-approved inhibitors in animal models for potential therapeutic use.
Description
This project aims to explore the role of KCa3.1 channels in atherosclerosis and evaluate the therapeutic potential of FDA-approved inhibitors in large animal models, with implications for human cardiovascular disease treatment.